{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T03:06:01Z","timestamp":1777086361652,"version":"3.51.4"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["NIAID T32 AI07024"],"award-info":[{"award-number":["NIAID T32 AI07024"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Roe Green Travel Medicine Award 2017, University Hospitals Cleveland Medical Center"},{"name":"Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional-FEDER, Red Espa\u00f1ola de Investigaci\u00f3n en SIDA","award":["RD16\/0025\/0026"],"award-info":[{"award-number":["RD16\/0025\/0026"]}]},{"name":"Xunta Galicia-Fondo Social Europeo","award":["IN606A-2016\/023"],"award-info":[{"award-number":["IN606A-2016\/023"]}]},{"name":"Fundaci\u00f3n Biom\u00e9dica Galicia Sur"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1093\/jac\/dkz134","type":"journal-article","created":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T20:10:44Z","timestamp":1552162244000},"page":"2024-2029","source":"Crossref","is-referenced-by-count":21,"title":["Prevalence of drug resistance mutations among ART-naive and -experienced HIV-infected patients in Sierra Leone"],"prefix":"10.1093","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8474-1812","authenticated-orcid":false,"given":"George A","family":"Yendewa","sequence":"first","affiliation":[{"name":"Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA"},{"name":"Division of Infectious Diseases and HIV Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, USA"},{"name":"Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Foday","family":"Sahr","sequence":"additional","affiliation":[{"name":"College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sulaiman","family":"Lakoh","sequence":"additional","affiliation":[{"name":"College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Ruiz","sequence":"additional","affiliation":[{"name":"Group of Virology and Pathogenesis, Galicia Sur Health Research Institute (IIS Galicia Sur)-Complexo Hospitalario Universitario de Vigo, SERGAS-UVigo, Vigo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Pati\u00f1o","sequence":"additional","affiliation":[{"name":"Group of Virology and Pathogenesis, Galicia Sur Health Research Institute (IIS Galicia Sur)-Complexo Hospitalario Universitario de Vigo, SERGAS-UVigo, Vigo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Tabernilla","sequence":"additional","affiliation":[{"name":"Group of Virology and Pathogenesis, Galicia Sur Health Research Institute (IIS Galicia Sur)-Complexo Hospitalario Universitario de Vigo, SERGAS-UVigo, Vigo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gibrilla F","family":"Deen","sequence":"additional","affiliation":[{"name":"College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Momodu","family":"Sesay","sequence":"additional","affiliation":[{"name":"National HIV\/AIDS Secretariat, Freetown, Sierra Leone"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A","family":"Salata","sequence":"additional","affiliation":[{"name":"Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA"},{"name":"Division of Infectious Diseases and HIV Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4835-9875","authenticated-orcid":false,"given":"Eva","family":"Poveda","sequence":"additional","affiliation":[{"name":"Group of Virology and Pathogenesis, Galicia Sur Health Research Institute (IIS Galicia Sur)-Complexo Hospitalario Universitario de Vigo, SERGAS-UVigo, Vigo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,4,15]]},"reference":[{"key":"2019062107501915100_dkz134-B1","year":"2016"},{"key":"2019062107501915100_dkz134-B2","year":"2016"},{"key":"2019062107501915100_dkz134-B3","year":"2015"},{"key":"2019062107501915100_dkz134-B4","year":"2006"},{"key":"2019062107501915100_dkz134-B5"},{"key":"2019062107501915100_dkz134-B6"},{"key":"2019062107501915100_dkz134-B7","year":"2016"},{"key":"2019062107501915100_dkz134-B8","year":"2017"},{"key":"2019062107501915100_dkz134-B9","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/jac\/dkv030","article-title":"Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional study","volume":"70","author":"Loubet","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2019062107501915100_dkz134-B10","doi-asserted-by":"crossref","first-page":"19315.","DOI":"10.7448\/IAS.17.1.19315","article-title":"Antiretroviral treatment outcome in HIV-1-infected patients routinely followed up in capital cities and remote areas of Senegal, Mali and Guinea-Conakry","volume":"17","author":"Diouara","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"2019062107501915100_dkz134-B11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/jac\/dky380","article-title":"Association between HIV-1 subtype and drug resistance in Nigerian infants","volume":"74","author":"Chaplin","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2019062107501915100_dkz134-B12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12985-015-0273-9","article-title":"High level of HIV-1 drug resistance among patients with HIV-1 and HIV-1\/2 dual infections in Guinea-Bissau","volume":"12","author":"Jespersen","year":"2015","journal-title":"Virol J"},{"key":"2019062107501915100_dkz134-B13","doi-asserted-by":"crossref","first-page":"e4724.","DOI":"10.1371\/journal.pone.0004724","article-title":"Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update","volume":"4","author":"Bennett","year":"2009","journal-title":"PLoS One"},{"key":"2019062107501915100_dkz134-B14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3201\/eid2203.150977","article-title":"Effects of response to 2014\u20132015 Ebola outbreak on deaths from malaria, HIV\/AIDS, and tuberculosis, West Africa","volume":"22","author":"Parpia","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"2019062107501915100_dkz134-B15","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1089\/aid.2014.0089","article-title":"Short communication: prevalence of HIV-1 transmitted drug resistance in Liberia","volume":"30","author":"Loubet","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2019062107501915100_dkz134-B16","year":"2017"},{"key":"2019062107501915100_dkz134-B17","year":"2018"},{"key":"2019062107501915100_dkz134-B18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2018.8431","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society-USA Panel","volume":"320","author":"Saag","year":"2018","journal-title":"JAMA"},{"key":"2019062107501915100_dkz134-B19","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1086\/496984","article-title":"Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis","volume":"41","author":"Sax","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2019062107501915100_dkz134-B20","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/QAI.0000000000001820","article-title":"Protease inhibitors or NNRTIs as first-line HIV-1 treatment in West Africa (PIONA): a randomized controlled trial","volume":"79","author":"Jespersen","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2019062107501915100_dkz134-B21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3851\/IMP1683","article-title":"Multi-nucleoside reverse transcriptase inhibitor resistant HIV type-1 in a patient from Sierra Leone failing stavudine, lamivudine and nevirapine","volume":"16","author":"Hamers","year":"2011","journal-title":"Antivir Ther"},{"key":"2019062107501915100_dkz134-B22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1468-1293.2005.00313.x","article-title":"HIV-1 subtypes in Spain: a retrospective analysis from 1995 to 2003","volume":"6","author":"Lospitao","year":"2005","journal-title":"HIV Med"},{"key":"2019062107501915100_dkz134-B23","first-page":"277","article-title":"HIV-1 subtype characteristics of infected persons living in southwestern Greece","volume":"7","author":"Davanos","year":"2015","journal-title":"HIV AIDS (Auckl)"},{"key":"2019062107501915100_dkz134-B24","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1099\/0022-1317-82-10-2509","article-title":"Molecular characterization of a complex, recombinant human immunodeficiency virus type 1 (HIV-1) isolate (A\/G\/J\/K\/?): evidence to support the existence of a novel HIV-1 subtype","volume":"82","author":"Paraskevis","year":"2001","journal-title":"J Gen Virol"},{"key":"2019062107501915100_dkz134-B25","first-page":"104","article-title":"HIV\/AIDS in Sierra Leone: characterizing the hidden epidemic","volume":"20","author":"Yendewa","year":"2018","journal-title":"AIDS Rev"},{"key":"2019062107501915100_dkz134-B26","first-page":"256982.","article-title":"The impact of HIV genetic polymorphisms and subtype differences on the occurrence of resistance to antiretroviral drugs","volume":"12","author":"Wainberg","year":"2012","journal-title":"Mol Biol Int"},{"key":"2019062107501915100_dkz134-B27","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.coviro.2012.08.006","article-title":"Are subtype differences important in HIV drug resistance?","volume":"2","author":"Lessells","year":"2012","journal-title":"Curr Opin Virol"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/advance-article-pdf\/doi\/10.1093\/jac\/dkz134\/28531928\/dkz134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/74\/7\/2024\/28851783\/dkz134.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T16:11:40Z","timestamp":1663085500000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/74\/7\/2024\/5464304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,15]]},"references-count":27,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,4,15]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkz134","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2019,4,15]]}}}